These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38402662)

  • 1. Corrigendum to "MEX3A promotes development and progression of breast cancer through regulation of PIK3CA" [Exp. Cell Res. 2021 Jul 1;404(1):112580. Epub 2021 Apr 1.].
    Shi X; Sun Y; Zhang Y; Wang W; Xu J; Guan Y; Ding Y; Yao Y
    Exp Cell Res; 2024 Mar; 436(1):113964. PubMed ID: 38402662
    [No Abstract]   [Full Text] [Related]  

  • 2. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA.
    Shi X; Sun Y; Zhang Y; Wang W; Xu J; Guan Y; Ding Y; Yao Y
    Exp Cell Res; 2021 Jul; 404(1):112580. PubMed ID: 33811903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway" [Gynecol Oncol. 2019 Jul;154(1):207-217. doi: 10.1016/j.ygyno.2019.04.005. Epub 2019 Apr 9].
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2024 Jan; 180():168-169. PubMed ID: 38091777
    [No Abstract]   [Full Text] [Related]  

  • 4. The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.
    Chen W; Hu L; Lu X; Wang X; Zhao C; Guo C; Li X; Ding Y; Zhao H; Tong D; Wang L; Huang C
    Breast Cancer Res Treat; 2023 Oct; 201(3):353-366. PubMed ID: 37433992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma.
    Wang X; Shan YQ; Tan QQ; Tan CL; Zhang H; Liu JH; Ke NW; Chen YH; Liu XB
    Cancer Cell Int; 2020; 20():63. PubMed ID: 32140076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
    Yan L; Li H; An W; Wei W; Zhang X; Wang L
    Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A.
    Chu J; Li T; Li L; Fan H
    Comput Math Methods Med; 2021; 2021():6591541. PubMed ID: 34765013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6.
    Wei L; Wang B; Hu L; Xu Y; Li Z; Shen Y; Huang H
    Aging (Albany NY); 2020 Nov; 12(21):21091-21113. PubMed ID: 33188661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway.
    Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z
    Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.
    Li F; Zhao C; Diao Y; Wang Z; Peng J; Yang N; Qiu C; Kong B; Li Y
    Cell Death Dis; 2022 Jun; 13(6):553. PubMed ID: 35715407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Using retinal function to define ischemic exclusion criteria for animal models of glaucoma" [Exp. Eye. Res. 202 (2021) 108354 doi: 10.1016/j.exer.2020.108354 Epub 2020 Nov 7].
    Hannon BG; Feola AJ; Gerberich BG; Read AT; Prausnitz MR; Ethier CR; Pardue MT
    Exp Eye Res; 2021 Sep; 210():108699. PubMed ID: 34243961
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Nerve fibre layer degeneration and retinal ganglion cell loss long term after optic nerve crush or transection in adult mice" [Exp Eye Res. (2018) 170:40-50. doi: 10.1016/j.exer.2018.02.010. Epub 2018 Feb 13].
    Sánchez-Migallón MC; Valiente-Soriano FJ; Salinas-Navarro M; Nadal-Nicolás FM; Jiménez-López M; Vidal-Sanz M; Agudo-Barriuso M
    Exp Eye Res; 2020 Jan; 190():107875. PubMed ID: 31757403
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
    FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MEX3A attenuates metastasis of breast cancer via β-catenin signaling pathway inhibition.
    Wang Y; Liang Q; Lei K; Zhu Q; Zeng D; Liu Y; Lu Y; Kang T; Tang N; Huang L; Ye L; Tang D; Zhu C
    Cancer Lett; 2021 Aug; 521():50-63. PubMed ID: 34425185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to"Survival of melanopsin expressing retinal ganglion cells long term after optic nerve trauma in mice" [Exp. Eye. Res. (2018) 174:93-97. doi: 10.1016/j.exer.2018.05.029. Epub 2018 May 29].
    Sánchez-Migallón MC; Valiente-Soriano FJ; Nadal-Nicolás FM; Di Pierdomenico J; Vidal-Sanz M; Agudo-Barriuso M
    Exp Eye Res; 2020 Jan; 190():107874. PubMed ID: 31757404
    [No Abstract]   [Full Text] [Related]  

  • 16. MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression.
    Zhou X; Li S; Ma T; Zeng J; Li H; Liu X; Li F; Jiang B; Zhao M; Liu Z; Qin Y
    Exp Ther Med; 2021 Nov; 22(5):1343. PubMed ID: 34630697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEX3A promotes nasopharyngeal carcinoma progression via the miR-3163/SCIN axis by regulating NF-κB signaling pathway.
    Xiang XX; Liu YL; Kang YF; Lu X; Xu K
    Cell Death Dis; 2022 Apr; 13(4):420. PubMed ID: 35490173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
    Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
    Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "The long non-coding RNA HOTAIR promotes the proliferation of serious ovarian cancer cells through the regulation of cell cycle arrest and apoptosis" [Exp. Cell Res. 333 (2015) 238-248].
    Qiu JJ; Wang Y; Ding JX; Jin HY; Yang G; Hua KQ
    Exp Cell Res; 2021 Mar; 400(1):112035. PubMed ID: 32448483
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway" [Exp. Cell Res. 390 (1) (1 May 2020) 111933].
    Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
    Exp Cell Res; 2021 Oct; 407(2):112836. PubMed ID: 34565520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.